Comparison of the Efficacy and Safety of NALDEBAIN With Conventional Treatment After Laparoscopic Cholecystectomy
PHASE4CompletedINTERVENTIONAL
Enrollment
44
Participants
Timeline
Start Date
July 1, 2018
Primary Completion Date
October 1, 2019
Study Completion Date
January 1, 2020
Conditions
Pain, Postoperative
Interventions
DRUG
Naldebain
150 mg Nalbuphine sebacate
DRUG
Morphine
Morphine
Trial Locations (1)
Unknown
Cathay General Hospital, Taipei
All Listed Sponsors
lead
Cathay General Hospital
OTHER
NCT03713216 - Comparison of the Efficacy and Safety of NALDEBAIN With Conventional Treatment After Laparoscopic Cholecystectomy | Biotech Hunter | Biotech Hunter